New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that ...

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

Afqlir is indicated to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) ...

Peking University researchers have developed a deep learning-based, noninvasive choroidal angiography method that enables ...

"AlloVir and Kalaris enter merger to advance retinal disease therapies" was originally created and published by ...

Age-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 ...

Sandoz (SDZNY) said that the European Commission has granted marketing authorization for Afqlir (aflibercept) 2 mg vial kit and ...

Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

SUMMARY: Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology ...